Bagheri H, Schmitt L, Berlan M, Montastruc J L
Laboratoire de Pharmacologie Médicale et Clinique, Inserm U317, Centre Hospitalier Universitaire, Faculté de Médecine, Toulouse, France.
Br J Clin Pharmacol. 1992 Dec;34(6):555-8. doi: 10.1111/j.1365-2125.1992.tb05661.x.
The effect of yohimbine treatment (4 mg three times daily) for 3 weeks on salivary secretion was investigated. In healthy volunteers, acute administration of yohimbine increased salivary volume within 1 h to a similar extent before and at the end of the treatment period. In depressed patients treated with tricyclic antidepressants (and exhibiting a reduced salivary flow), yohimbine also acutely increased salivary volume. In contrast, the alpha 2-adrenoceptor antagonist failed to modify resting values measured in the morning (i.e. 10 and 14 h after the last administration in healthy volunteers and depressed patients respectively). This result indicates that alpha 2-adrenoceptor antagonists may have a potential therapeutic use in the treatment of dry mouth caused by tricyclic antidepressant drugs.
研究了育亨宾治疗(每日3次,每次4毫克,持续3周)对唾液分泌的影响。在健康志愿者中,急性给予育亨宾在1小时内使唾液量增加,在治疗期开始前和结束时增加程度相似。在用三环类抗抑郁药治疗(且唾液流量降低)的抑郁症患者中,育亨宾也能急性增加唾液量。相比之下,α2肾上腺素能受体拮抗剂未能改变早晨测得的静息值(即分别在健康志愿者和抑郁症患者最后一次给药后10小时和14小时)。这一结果表明,α2肾上腺素能受体拮抗剂在治疗三环类抗抑郁药引起的口干方面可能具有潜在的治疗用途。